Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population

Purpose: To estimate CFTR mutation frequencies, clinical sensitivities (proportions of carrier couples or affected fetuses detected), and birth prevalence estimates for broad racial/ethnic groups and for a panethnic U.S. population.Methods: Published sources of information were identified, corrected when appropriate, and summarized. Combining racial/ethnic-specific mutation frequencies and birth prevalence estimates allowed the computation of panethnic estimates.Results: Two of the 25 recommended mutations do not meet the 0.1% threshold in a panethnic population set by the American College of Medical Genetics. The clinical sensitivities are estimated to be 71.9%, 51.7%, 41.6%, 88.6%, and 23.4% for non-Hispanic Caucasians, Hispanic Caucasian, African American, Ashkenazi Jewish Caucasian, and Asian American couples, respectively. Birth prevalence estimates are 1:2,500, 1:13,500, 1:15,100, 1:2,270, and 1:35,100, whereas the number of couples needed to screen to detect an affected fetus are about 3,200, 26,120; 36,040; 2,600, and 129,600, respectively, for the same racial/ethnic groups.Conclusions: Overall, the panethnic estimates for CFTR mutation frequencies are similar to those for non-Hispanic Caucasians. However, large differences in both clinical sensitivity and birth prevalence exist between the broad racial/ethnic groups examined. Whether and how the differences in the numbers of couples needed to screen to detect an affected fetus are to be included in prenatal screening for cystic fibrosis needs to be more explicitly addressed.

[1]  J. Martin,et al.  Births: final data for 2002. , 2003, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[2]  C. Rodeck,et al.  Cystic fibrosis: selecting the prenatal screening strategy of choice , 2022 .

[3]  M. Knowles,et al.  The I148T CFTR allele occurs on multiple haplotypes: A complex allele is associated with cystic fibrosis , 2002, Genetics in Medicine.

[4]  J. Haddow,et al.  Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians , 2002, Genetics in Medicine.

[5]  R. Heim,et al.  Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel , 2001, Genetics in medicine : official journal of the American College of Medical Genetics.

[6]  K. Klinger,et al.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening , 2001, Genetics in Medicine.

[7]  A. Hamosh,et al.  Comparison of the clinical manifestations of cystic fibrosis in black and white patients. , 1998, The Journal of pediatrics.

[8]  A. Macková,et al.  Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. , 1997, American journal of human genetics.

[9]  C. Springer,et al.  Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel , 1995, Human Genetics.

[10]  C. Springer,et al.  Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. , 1992, American journal of human genetics.

[11]  R. Loewenthal,et al.  Prevalence of cystic fibrosis mutations in Israeli Jews. , 2001, Genetic testing.

[12]  M. Macek,et al.  Case report of a Thai male cystic fibrosis patinet with the 1898+ 1G-->T splicing mutation in the CFTR gene: a review of East Asian cases. Mutations in brief no. 196. Online. , 1998, Human mutation.

[13]  Milan Macek,et al.  Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene , 1997, Human mutation.

[14]  B. Kerem,et al.  Cystic fibrosis in Jews: frequency and mutation distribution. , 1997, Genetic testing.

[15]  J. Cheadle,et al.  Population variation of common cystic fibrosis mutations , 1994 .